Sinovac Biotech's market cap is currently $460.27M. The company's EPS TTM is $-1.312; its P/E ratio is ―; Sinovac Biotech is scheduled to report earnings on May 5, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 448.27M	$ 1.49B	$ 19.37B	$ 510.62M	$ 246.05M
Gross Profit	$ 266.75M	$ 808.30M	$ 18.30B	$ 443.44M	$ 213.58M
Operating Income	$ -546.72M	$ -466.07M	$ 17.55B	$ 215.64M	$ 68.56M
EBITDA	$ -6.03M	$ 183.10M	$ 17.65B	$ 221.76M	$ 76.05M
Net Income	$ -99.92M	$ 113.87M	$ 8.47B	$ 110.37M	$ 44.93M
Balance Sheet
Cash & Short-Term Investments	$ 11.22B	$ 11.31B	$ 13.42B	$ 1.18B	$ 202.99M
Total Assets	$ 13.66B	$ 14.11B	$ 16.75B	$ 1.90B	$ 452.30M
Total Debt	$ 298.98M	$ 74.67M	$ 144.91M	$ 136.39M	$ 20.27M
Net Debt	$ -971.15M	$ -4.20B	$ -11.46B	$ -904.62M	$ -132.45M
Total Liabilities	$ 1.64B	$ 1.40B	$ 2.87B	$ 781.20M	$ 100.10M
Stockholders' Equity	$ 8.71B	$ 8.92B	$ 9.33B	$ 746.47M	$ 294.02M
Cash Flow
Free Cash Flow	$ -41.69M	$ -1.17B	$ 14.63B	$ 351.66M	$ 28.45M
Operating Cash Flow	$ 104.00M	$ -770.75M	$ 15.35B	$ 479.31M	$ 39.07M
Investing Cash Flow	$ -2.93B	$ -5.76B	$ -3.02B	$ -204.76M	$ -42.45M
Financing Cash Flow	$ -76.06M	$ -241.40M	$ -1.90B	$ 592.57M	$ 1.74M

Currency in USD

Sinovac Biotech Earnings and Revenue History

Income Statement >

Sinovac Biotech Debt to Assets

Balance Sheet >

Sinovac Biotech Cash Flow

Cash Flow >

Sinovac Biotech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing